The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
B-PRECISE-01 Study: A phase Ib trial of MEN1611, a PI3K Inhibitor, combined with trastuzumab ± fulvestrant for the treatment of HER2-positive advanced or metastatic breast cancer.
 
Martine J. Piccart-Gebhart
Consulting or Advisory Role - AstraZeneca; Camel-IDS; Crescendo Biologics; Debiopharm Group; G1 Therapeutics; HUYA Bioscience International; Immunomedics; Lilly; Menarini; MSD; Novartis; Odonate Therapeutics; Oncolytics; Periphagen; Pfizer; PharmaMar; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Roche/Genentech (Inst); Servier (Inst); Synthon (Inst)
Other Relationship - Radius Health
 
Philippe Georges Aftimos
Honoraria - Roche; Synthon
Consulting or Advisory Role - Amcure; Amgen; Boehringer Ingelheim; Macrogenics; Novartis; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; MSD Oncology; Pfizer; Roche Belgium
 
Francois P. Duhoux
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche; Teva
 
Hans Wildiers
Honoraria - Amgen; Novartis; Roche
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Lilly (Inst); Roche (Inst); Vifor Pharma (Inst)
Research Funding - Roche (Inst)
Expert Testimony - Abbvie; TRM Oncology
Travel, Accommodations, Expenses - Pfizer; Puma Biotechnology; Roche; TRM Oncology
 
Nicolas Isambert
Travel, Accommodations, Expenses - AstraZeneca; Celgene; MedImmune; Novartis; PharmaMar; Roche/Genentech
 
Mario Campone
Honoraria - Menarini; Novartis; Servier
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Sanofi (Inst); SERVIER (Inst)
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Roche
 
Diego Tosi
Consulting or Advisory Role - Biomarin (I)
Research Funding - Astellas Pharma; Janssen; Novartis
Patents, Royalties, Other Intellectual Property - I have a pending patent on a new drug combination for prostate cancer treatment
Travel, Accommodations, Expenses - Amicus Therapeutics (I); Astellas Pharma; Astellas Pharma; Janssen; Nutricia (I); Pfizer
 
Andrea I. Varga
Consulting or Advisory Role - Clovis Oncology
Research Funding - , Boehringer Ingelheim (Inst); , Janssen Cilag, (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Roche
 
Valentina Boni
Honoraria - Loxo
Consulting or Advisory Role - Guidepoint Global; OncoArt
Speakers' Bureau - Solti
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); CytomX Therapeutics (Inst); Incyte (Inst); Janssen Oncology (Inst); Kura Oncology (Inst); Lilly (Inst); Loxo (Inst); Menarini (Inst); Merck (Inst); Merus (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Synthon (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - START
 
Bernard Doger
No Relationships to Disclose
 
Javier Garcia Corbacho
No Relationships to Disclose
 
Begona Jimenez-Rodriguez
No Relationships to Disclose
 
Manuel Ruiz Borrego
No Relationships to Disclose
 
Cristina Saura
Consulting or Advisory Role - AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Genomic Health; Novartis; Pfizer; Pierre Fabre; Puma Biotechnology; Roche; Synthon
Research Funding - AstraZeneca (Inst); Genentech (Inst); Macrogenics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Synthon (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Genomic Health; Genomic Health; Novartis; Pfizer; Puma Biotechnology; Roche; Roche
 
Hendrik-Tobias Arkenau
Employment - Hospital Corporation of America
Honoraria - BeiGene; Bicycle Therapeutics; Guardant Health; Merck KGaA; Roche; SERVIER
 
Andrew M. Wardley
Stock and Other Ownership Interests - Andrew Wardley Limited
Honoraria - AstraZeneca; Lilly; Novartis; Roche
Consulting or Advisory Role - Accord Research; Amgen; AstraZeneca; AstraZeneca; Athenex; Coleman Research; Daiichi Sankyo; Gerson Lehrman Group; Guidepoint Global; Lilly; MSD Oncology; NAPP Pharmaceuticals; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Eisai; Lilly; Novartis; Pfizer; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche
 
Inaki F Troconiz
Consulting or Advisory Role - Menarini; Menarini (Inst); MSD; MSD (Inst)
Research Funding - Lilly (Inst); Menarini (Inst); Moderna Therapeutics (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Menarini; MSD
 
Monica Binaschi
Employment - Menarini
 
Cecilia Simonelli
Employment - Menarini Silicon Biosystems
 
Andrea Ugo Pellacani
Employment - Menarini
Leadership - Menarini
Stock and Other Ownership Interests - Amgen; Amgen (I)